Per Bernell

739 total citations
27 papers, 523 citations indexed

About

Per Bernell is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Per Bernell has authored 27 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Molecular Biology. Recurrent topics in Per Bernell's work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Per Bernell is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). Per Bernell collaborates with scholars based in Sweden, Denmark and Norway. Per Bernell's co-authors include Robert Hast, B Jacobsson, Jonas Wallvik, Lotta Ohm, Leif Stenke, Ingrid Arvidsson, Heléne Hallböök, Ann Nordgren, Erik Hulegårdh and Erik Hippe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Per Bernell

27 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Bernell Sweden 15 336 190 133 119 112 27 523
CA Hurwitz United States 7 347 1.0× 274 1.4× 118 0.9× 95 0.8× 92 0.8× 8 485
R Battista Italy 14 278 0.8× 282 1.5× 91 0.7× 159 1.3× 79 0.7× 42 581
E R van Wering Netherlands 11 284 0.8× 246 1.3× 144 1.1× 44 0.4× 72 0.6× 14 467
Saverio Ladogana Italy 13 305 0.9× 187 1.0× 89 0.7× 84 0.7× 42 0.4× 33 432
Mette Skov Holm Denmark 9 451 1.3× 132 0.7× 272 2.0× 159 1.3× 71 0.6× 19 623
Regina Reutzel Germany 7 295 0.9× 286 1.5× 69 0.5× 60 0.5× 86 0.8× 8 493
JM Boyett United States 12 332 1.0× 505 2.7× 96 0.7× 108 0.9× 199 1.8× 17 657
U. Creutzig Germany 11 456 1.4× 287 1.5× 140 1.1× 64 0.5× 61 0.5× 35 550
Pilar Bastida Spain 11 277 0.8× 405 2.1× 71 0.5× 50 0.4× 224 2.0× 19 572
Olga Militano United States 12 247 0.7× 134 0.7× 55 0.4× 55 0.5× 78 0.7× 42 446

Countries citing papers authored by Per Bernell

Since Specialization
Citations

This map shows the geographic impact of Per Bernell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Bernell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Bernell more than expected).

Fields of papers citing papers by Per Bernell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Bernell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Bernell. The network helps show where Per Bernell may publish in the future.

Co-authorship network of co-authors of Per Bernell

This figure shows the co-authorship network connecting the top 25 collaborators of Per Bernell. A scholar is included among the top collaborators of Per Bernell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Bernell. Per Bernell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozlowski, Piotr B., Maria Åström, Lucia Ahlberg, et al.. (2014). High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper‐CVAD chemotherapy in Sweden. European Journal Of Haematology. 92(5). 377–381. 25 indexed citations
2.
Kozlowski, Piotr B., Maria Åström, Lucia Ahlberg, et al.. (2012). High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007. Haematologica. 97(9). 1414–1421. 19 indexed citations
3.
Grövdal, Michael, Mohsen Karimi, Anni Aggerholm, et al.. (2010). Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. British Journal of Haematology. 150(3). 293–302. 44 indexed citations
4.
Nahi, Hareth, H Hägglund, Tomas Ahlgren, et al.. (2008). An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients. Haematologica. 93(11). 1734–1738. 15 indexed citations
5.
Wallvik, Jonas, Leif Stenke, Per Bernell, et al.. (2002). Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes. European Journal Of Haematology. 68(3). 180–186. 29 indexed citations
6.
Hast, Robert, et al.. (2001). Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment. Leukemia Research. 25(1). 13–18. 17 indexed citations
7.
8.
Celsing, Fredrik, Susanne Widell, K. Merk, et al.. (1998). Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin’s lymphoma. Annals of Oncology. 9(11). 1213–1217. 9 indexed citations
9.
Bernell, Per & Lotta Ohm. (1998). Promising activity of gemcitabine in refractory high‐grade non‐Hodgkin's lymphoma. British Journal of Haematology. 101(1). 203–204. 28 indexed citations
10.
Bernell, Per, Ingrid Arvidsson, Robert Hast, Björn Jacobsson, & Leif Stenke. (1997). Differences in cell lineage involvement between MDS‐AML and de novo AML studied by fluorescence in situ hybridization in combination with morphology. European Journal Of Haematology. 58(4). 241–245. 5 indexed citations
11.
Bernell, Per, Ingrid Arvidsson, Björn Jacobsson, & Robert Hast. (1996). Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia. British Journal of Haematology. 95(4). 666–672. 25 indexed citations
12.
Bernell, Per, et al.. (1996). A sequential erythropoietin and GM-CSF schedule offers clinical benefits in the treatment of anaemia in myelodysplastic syndromes. Leukemia Research. 20(8). 693–699. 16 indexed citations
13.
Bernell, Per, B Jacobsson, Ann Nordgren, & Robert Hast. (1996). Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.. PubMed. 10(4). 662–8. 44 indexed citations
14.
Jacobsson, B, Per Bernell, Ingrid Arvidsson, & Robert Hast. (1996). Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears.. Journal of Histochemistry & Cytochemistry. 44(11). 1303–1309. 14 indexed citations
15.
Hast, Robert & Per Bernell. (1992). Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice. Leukemia Research. 16(1). 8–9. 1 indexed citations
16.
Hast, Robert, et al.. (1991). (A9) Dysplastic changes of peripheral blood polymorphs in elderly de novo AML patients — sign of a link to MDS?. Leukemia Research. 15. 2–2. 1 indexed citations
17.
Bernell, Per, et al.. (1991). Increase of serum interleukin‐2 and regression of myeloma after rhGM‐CSF treatment of drug induced bone marrow aplasia. Hematological Oncology. 9(3). 129–135. 4 indexed citations
18.
Pisa, Pavel, Leif Stenke, Per Bernell, Mona Hansson, & Robert Hast. (1990). Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients.. PubMed. 10(3). 817–20. 14 indexed citations
19.
Hast, Robert, Per Bernell, & Mona Hansson. (1989). Cimetidine as an immune response modifier. Medical Oncology and Tumor Pharmacotherapy. 6(1). 111–113. 8 indexed citations
20.
Hast, Robert, et al.. (1986). Decrease in helper (T4+) lymphocytes following cimetidine treatment for duodenal ulcer.. PubMed. 64(1). 114–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CA Hurwitz Breakdown of academic impact, for papers by R Battista Breakdown of academic impact, for papers by E R van Wering Breakdown of academic impact, for papers by Saverio Ladogana Breakdown of academic impact, for papers by Mette Skov Holm Breakdown of academic impact, for papers by Regina Reutzel Breakdown of academic impact, for papers by JM Boyett Breakdown of academic impact, for papers by U. Creutzig Breakdown of academic impact, for papers by Pilar Bastida Breakdown of academic impact, for papers by Olga Militano
Rankless by CCL
2026